Dolly Chhabria, a 37-year-old expecting mother from the UK, faced a harrowing situation when a routine pregnancy scan revealed abnormalities that led to a suspicion of cancer. After undergoing non-invasive prenatal testing (NIPT), she was informed of a 50 percent chance of cancer, which was confirmed by a biopsy after she had to wait until childbirth to begin treatment. This unnerving experience left her in constant turmoil, fearing that she might not live to see her daughter grow up.

The scan's findings prompted a series of medical evaluations, including a full-body MRI that identified disturbing masses above her heart and around her collarbone. Despite these alarming results, the medical team decided to postpone any cancer treatment until after the delivery of her child. Dolly's story highlights the critical balance that expectant mothers often have to navigate between ensuring their health and that of their unborn child.

Dolly finally welcomed her daughter, Edha, on March 25, 2024, after a full-term pregnancy, and immediately afterwards began intensive chemotherapy treatment. This narrative underscores not only the challenges faced by pregnant women diagnosed with serious health issues but also the emotional and physical toll it takes on families awaiting the arrival of a newborn in such circumstances.